US18271L1070 - Common Stock
CLARUS THERAPEUTICS HOLDINGS
NASDAQ:CRXT (8/30/2022, 7:05:42 PM)
After market: 0.101 +0 (+2.02%)0.099
-0.06 (-36.94%)
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company, which engages in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company is headquartered in Northbrook, Illinois and currently employs 16 full-time employees. The company went IPO on 2020-12-17. The firm is focused on the commercialization of JATENZO, an oral T-replacement, or T-replacement therapy (TRT). The Company’s lead product, JATENZO, an androgen indicated for T-replacement therapy to treat adult men with hypogonadism due to certain medical conditions. In addition, JATENZO focuses on the classic signs and symptoms associated with hypogonadism, including psychosexual symptoms, body mass index, fat mass and bone mineral density. The firm plans to focused on the development and commercialization of T and metabolic therapies for men and women.
CLARUS THERAPEUTICS HOLDINGS
555 Skokie Boulevard, Suite 340
Northbrook ILLINOIS
P: 16463030737.0
CEO: Joseph Hernandez
Employees: 16
Website: https://clarustherapeutics.com/
Court-supervised auction for JATENZO (testosterone undecanoate capsules; C-III) concluded on October 14, 2022 NORTHBROOK, Ill., Oct. 18, 2022 (GLOBE...
Bidding process and auction for JATENZO (testosterone undecanoate capsules; C-III) projected to conclude late October 2022...
It's time for another breakdown of the biggest pre-market stock movers as we go over the latest news on Tuesday morning.
Pinduoduo (PDD) stock is getting a boost on Monday after the Chinese agriculture tech company released results for Q2 2022.
Fans of AMC Entertainment (AMC) stock will want to keep an eye on the company come Sept. 3 as it prepares for a special theater event.
Here you can normally see the latest stock twits on CRXT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: